Global Foot and Mouth Disease Market Driven by Governments Initiatives to Eradicate the Disease: Technavio

Technavio has published a new report on the global foot and mouth disease (FMD) vaccines market from 2017-2021. (Graphic: Business Wire)

LONDON--()--According to the latest market study released by Technavio, the global foot and mouth disease (FMD) vaccine market is projected to grow to USD 985.94 million by 2021, at a CAGR of close to 9% over the forecast period.

This research report titled ‘Global Foot and Mouth Disease Vaccine Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.

Foot and mouth disease is a contagious viral disease that affects livestock. Governments of various countries are looking to eradicate the disease completely, which is leading to the high adoption of the foot and mouth disease vaccine,” says Sapna Jha, a lead analyst at Technavio for vaccines research.

Request a sample report: http://www.technavio.com/request-a-sample?report=57216

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Based on application, the report categorizes the global foot and mouth disease vaccine market into the following segments:

  • Cattle
  • Pigs
  • Sheep and goats
  • Others

The top three revenue-generating application segments in the global foot and mouth disease vaccine market are discussed below:

Cattle

Over 70% of the overall revenue generated in the global FMD vaccines market is from the cattle segment. The high adoption in the market segment can be attributed to the presence of an increasing number of cattle to meet the increased demand for its livestock products. Currently, India accounts for the largest cattle inventory worldwide, followed by Brazil and China. With the growing demand for cattle products worldwide, there is an increased need to reduce the impact of FMD outbreaks, leading to high demand for the FMD vaccine.

Pigs

“Pigs are bred on a large scale to cater to the growing demand for meat as they are a fast-growing species with efficient feed conversion rates. The need to contain the FMD outbreaks in the large populations of pigs in North America, Europe, the Middle East, and Africa create a significant demand for the FMS vaccines,” says Sapna.

Another important reason for the large demand for FMD vaccines from this segment is the need for their re-administration every six months. Also, the widespread foot and mouth disease outbreaks in many countries such as South Korea, Armenia, and Israel will drive the adoption rates substantially.

Sheep and goats

Sheep and goats are valued livestock animals and create substantial demand for foot and mouth disease vaccines. Since the prevalence of FMD in sheep and goat is relatively lower when compared to the other common livestock animals, the market segment’s market share is limited. However, the recent foot and mouth disease outbreak among sheep and goats in the Indian subcontinent is driving the increased adoption of the vaccine.

The top vendors highlighted by Technavio’s research analysts in this report are:

  • Biogénesis Bagó
  • Boehringer Ingelheim
  • Brilliant Bio Pharma
  • Indian Immunologicals
  • Merck

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like cardiovascular devices, central nervous system, and in-vitro diagnostics. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

According to the latest market study released by Technavio, the global foot and mouth disease (FMD) vaccine market is projected to grow to USD 985.94 million by 2021, at a CAGR of close to 9%.

$Cashtags

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com